Apotex Corp. is recalling approximately 292,752 bottles of Fluticasone Propionate Nasal Spray USP 50mcg. This prescription allergy medication is being recalled due to manufacturing deviations that may have led to the presence of Burkholderia cepacia complex bacteria. The recall involves 16g bottles containing 120 metered sprays identified by NDC 60505-0829-1.
Burkholderia cepacia complex is a group of bacteria that can cause serious, potentially life-threatening infections in individuals with weakened immune systems or chronic lung conditions like cystic fibrosis. No injuries or illnesses have been reported to date regarding this recall.
You have 2 options:
Recall #: D-0326-2024; Manufactured by Apotex Inc. in Toronto, Canada; Manufactured for Apotex Corp. in Weston, FL.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.